Pivotal Data Demonstrating Efficacy Of Plenadren® (Hydrocortisone, Modified ... Daily Markets 16, 2012 /PRNewswire/ – ViroPharma Incorporated (NASDAQ:VPHM) today announced that data from the pivotal study for their orphan drug Plenadren® (hydrocortisone, modified release tablet) were published in the Journal of Clinical Endocrinology and ... |
